Child Categories
Medical Technology
-
Mateo Aboy, Kathleen Liddell, Cristina Crespo, I. Glenn Cohen, Johnathon Liddicoat, Sara Gerke & Timo Minssen, How Does Emerging Patent Case Law in the US…
-
Effy Vayena, Alessandro Blasimme & I. Glenn Cohen, Machine Learning in Medicine: Addressing Ethical Challenges, 15 PLoS Med. e1002689 (2018).
-
Medical Tourism, Medical Migration, and Global Justice: Implications for Biosecurity in a Globalized World
July 16, 2026
I. Glenn Cohen, Medical Tourism, Medical Migration, and Global Justice: Implications for Biosecurity in a Globalized World, 25 Med. L. Rev. 200 (2017).
-
FDA Regulation of Mobile Health Technologies
July 16, 2026
Nathan G. Cortez, I. Glenn Cohen & Aaron S. Kesselheim, FDA Regulation of Mobile Health Technologies, 370 New Eng. J. Med. 372 (2014).
-
Genetic Advances and Legal Institutions
July 14, 2026
Stephen Breyer, Genetic Advances and Legal Institutions, 28 J.L., Med. & Ethics 23 (2000).
-
Drug Discovery and Genomics: Accelerating Medical Innovation Through Artificial Intelligence
July 14, 2026
Michael E. Matheny, Nakul Aggarwal, Carmel Shachar et al., Drug Discovery and Genomics: Accelerating Medical
Innovation Through Artificial Intelligence (Nov. 13, 2025). -
Data Overload in the Digital Age: Can Digital Phenotyping Create Liability for Clinicians?
July 14, 2026
Miranda Skurla, Sara Gerke, Weronika Pasciak et al., Data Overload in the Digital Age: Can Digital Phenotyping Create Liability for Clinicians?, 33 The American Journal…
-
Carmel Shachar, Emmanuel F. Drabo, Theodore J. Iwashyna et al., Addressing Racial and Ethnic Bias in Pulse Oximeters—A Wicked Problem, 333 JAMA 563 (2024).
-
The Council of Europe’s AI Convention (2023-2024): Promises and Pitfalls for Health Protection
July 14, 2026
Hannah van Kolfschooten & Carmel Shachar, The Council of Europe’s AI Convention (2023-2024): Promises and Pitfalls for Health Protection, 138 Health Pol’y (2023).
-
Nakul Aggarwal, Mahnoor Ahmed, Sanjay Basu et al., Advancing Artificial Intelligence in Health Settings Outside the Hospital and Clinic (Nat’l Acad. Med. Discussion Paper, 2020).
-
David A. Simon & Carmel Shachar, Telehealth to Address Health Disparities: Potential, Pitfalls, and Paths Ahead, 49 J. L. Med. & Ethics 415 (2021).
-
Carmel Shachar & Sara Gerke, Prevention of Bias and Discrimination in Clinical Practice Algorithms, 329 JAMA 283 (2023).
-
The oversight of autonomous artificial intelligence: lessons from nurse practitioners as physician extenders
July 14, 2026
Walker Morrell, Carmel Shachar & Anthony P. Weiss, The oversight of autonomous artificial intelligence: lessons from nurse practitioners as physician extenders, 9 J. L. &…
-
Carmel Shachar, Jaclyn Engel & Glyn Elwyn, Implications for Telehealth in a Postpandemic Future: Regulatory and Privacy Issues, 323 JAMA 2375 (2020).
-
Samuel G. Finlayson, Adarsh Subbaswamy, Karandeep Singh, John Bowers, Annabel Kupke, Jonathan Zittrain, Isaac S. Kohane & Suchi Saria, The Clinician and Dataset Shift in…
-
Coronavirus Testing Is on the Brink of Paralysis
July 14, 2026
Margaret Bourdeaux, Beth Cameron & Jonathan Zittrain, Opinion, Coronavirus Testing Is on the Brink of Paralysis, N.Y. Times, July 17, 2020, at A25.
-
Is Digital Contact Tracing Over Before It Began?
July 14, 2026
Jonathan Zittrain, Is Digital Contact Tracing Over Before It Began?, Medium (June 25, 2020).
-
Entering the Minefield of Digital Contact Tracing
July 14, 2026
Jonathan Zittrain, Entering the Minefield of Digital Contact Tracing, Medium (May 5, 2020).
-
The Hidden Costs of Automated Thinking
July 14, 2026
Jonathan Zittrain, The Hidden Costs of Automated Thinking, NewYorker.com (July 23, 2019).
-
What the Publisher Can Teach the Patient: Intellectual Property and Privacy in an Era of Trusted Privication
July 14, 2026
Jonathan L. Zittrain, What the Publisher Can Teach the Patient: Intellectual Property and Privacy in an Era of Trusted Privication, 52 Stan. L. Rev. 1201…
-
Innovation and policy challenges of AI–drug hybrids
July 14, 2026
Andreas Panagopoulos, Katerina Sideri, I. Glenn Cohen et al., Innovation and policy challenges of AI–drug hybrids, 44 Nature Biotechnology 365 (2026).